Physician profile
Bruce E Reid
NPI 1104859461
$6,485.38
in general payments reported to CMS, 2019-2025
8 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $126 · 2021: $663 · 2022: $1,482 · 2023: $2,031 · 2024: $1,380 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,030 · Travel and Lodging: $1,682 · Entertainment: $32.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,030.42 |
| Travel and Lodging | $1,682.23 |
| Entertainment | $32.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $3,354.44 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $1,390.32 | 2019-2024 | Precision 1, Total30 |
| Johnson & Johnson Vision Care, INC. | $980.58 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $589.83 | 2022-2025 | Infuse, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $117.91 | 2019-2021 | |
| Optos, INC. | $32.16 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Visioneering Technologies, INC. | $11.99 | 2022 | |
| Biotissue Holdings INC. | $8.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.